News for Relmada Therapeutics Inc Stock (RLMD)

Relmada Therapeutics Inc Is Under Investigation By The Schall Law Firm For Possible Securities Violations And Impacted Investors Are Urged To Establish Dialogue

Accesswire • 07/10/24

Relmada Therapeutics Inc Is Being Probed By The Schall Law Firm For Potential Securities Breaches And Affected Investors Are Encouraged To Set Up Communication

Accesswire • 07/09/24

Relmada Therapeutics Inc Is Under Investigation By The Schall Law Firm For Possible Securities Violations And Impacted Investors Are Urged To Establish Communication

Accesswire • 07/08/24

The Schall Law Firm Begins Probe Into Relmada Therapeutics Inc For Suspected Securities Violations And Promotes Investors With Losses To Get In Touch

Accesswire • 07/07/24

Investigation Into Possible Securities Infringements By Relmada Therapeutics Inc Is Being Conducted By The Schall Law Firm And It Invites Affected Investors To Reach Out

Accesswire • 07/06/24

The Schall Law Firm Initiates Examination Into Relmada Therapeutics Inc For Potential Securities Breaches And Encourages Impacted Investors To Establish Contact

Accesswire • 07/05/24

The Schall Law Firm Investigates Relmada Therapeutics Inc For Potential Securities Breaches And Encourages Impacted Investors To Connect

Accesswire • 07/03/24

The Schall Law Firm Probes Relmada Therapeutics Inc For Possible Securities Violations And Urges Affected Investors To Contact

Accesswire • 07/02/24

The Schall Law Firm Is Investigating Relmada Therapeutics Inc For Potential Infringements Of Securities Regulations And Encourages Investors Who Experienced Losses To Make Contact

Accesswire • 06/28/24

The Schall Law Firm Is Probing Relmada Therapeutics Inc For Possible Breaches Of Securities Laws And Urges Investors Who Sustained Losses To Reach Out

Accesswire • 06/27/24

The Schall Law Firm Is Investigating Relmada Therapeutics Inc For Potential Securities Law Violations And Encourages Investors With Losses To Contact

Accesswire • 06/25/24

The Schall Law Firm Is Probing Relmada Therapeutics Inc For Possible Securities Law Breaches And Urges Investors Who Incurred Losses To Reach Out

Accesswire • 06/24/24

Potential Violations Of Securities Laws By Relmada Therapeutics Inc Are Being Investigated By The Schall Law Firm Investors Who Have Suffered Losses Are Encouraged To Connect With The Firm

Accesswire • 06/23/24

Possible Breaches Of Securities Laws By Relmada Therapeutics Inc Are Being Probed By The Schall Law Firm Investors With Financial Losses Are Invited To Reach Out To The Firm

Accesswire • 06/22/24

Potential Violations Of Securities Laws By Relmada Therapeutics Inc Are Under Investigation By The Schall Law Firm Investors Who Have Incurred Financial Losses Are Encouraged To Contact The Firm

Accesswire • 06/19/24

The Schall Law Firm Is Probing Potential Securities Breaches By Relmada Therapeutics Inc Investors With Monetary Losses Are Urged To Reach Out To The Firm

Accesswire • 06/18/24

Relmada Therapeutics Announced Publication of Results from the Phase 3 Reliance I Study of REL-1017 in The Journal of Clinical Psychiatry

PRNewsWire • 06/18/24

Relmada Therapeutics Inc. (NASDAQ: RLMD) Under Investigation By Schall Law Firm For Potential Securities Violations. Investors Who Lost Money Encouraged To Contact The Firm

Accesswire • 06/17/24

Claims Against Relmada Therapeutics, Inc.: Schall Law Firm Starts Investigation And Invites Affected Investors To Get In Touch

Accesswire • 06/11/24

Relmada Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

PRNewsWire • 06/10/24

Accusations Made Against Relmada Therapeutics, Inc.: Schall Law Firm Commences Probe And Calls On Impacted Investors To Participate

Accesswire • 06/09/24

Charges Leveled At Relmada Therapeutics, Inc.: Schall Law Firm Begins Investigation And Invites Impacted Investors To Engage.

Accesswire • 06/08/24

Accusations Against Relmada Therapeutics, Inc.: Schall Law Firm Initiates Probe And Calls On Impacted Investors To Connect

Accesswire • 06/07/24

Allegations Against Relmada Therapeutics, Inc.: Schall Law Firm Starts Investigation and Urges Impacted Investors to Reach Out

Accesswire • 06/06/24

Relmada Therapeutics, Inc. Allegations: Schall Law Firm Initiates Inquiry and Invites Affected Investors to Connect

Accesswire • 06/05/24